Clinical Trial Update: Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1) [Phase 2]

View source ↗

Summary

Phase 2 trial update on the efficacy and safety of gemcabene in patients with homozygous familial hypercholesterolemia on stable lipid-lowering therapy (COBALT-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• gemcabene (gemcabene)

Snippet

Sponsor: NeuroBo Pharmaceuticals Inc. | Conditions: Hypercholesteremia | Phase 2 | Status: COMPLETED | Results posted: 2020-06-25